English | 简体中文 | 繁體中文 | 한국어
Share:
Tecan to present at Jefferies London Healthcare Conference

Tecan Group AG / Tecan to present at Jefferies London Healthcare Conference . Processed and transmitted by West Corporation. The issuer is solely responsible for the content of this announcement.

Männedorf, Switzerland, November 8, 2018 - The Tecan Group (SIX Swiss Exchange: TECN) today announced that it will present at the Jefferies London Healthcare Conference on November 14, 2018.

The investor presentation by David Martyr, CEO of Tecan, will begin at 1:20 pm GMT (2:20 pm CET) and will be webcast live. The webcast may be accessed under the "Investor Relations" tab of Tecan's website www.tecan.com.

A replay of the webcast will be available after the presentation and will remain available for 90 days.

About Tecan
Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. The company specializes in the development, production and distribution of automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, forensic and diagnostic laboratories. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2017, Tecan generated sales of CHF 548 million (USD 560 million; EUR 494 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TECN; ISIN CH0012100191).

For further information:

Tecan Group
Martin Braendle
Vice President, Communications & Investor Relations
Tel. +41 (0) 44 922 84 30
Fax +41 (0) 44 922 88 89
[email protected]
www.tecan.com




This announcement is distributed by West Corporation on behalf of West Corporation clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Tecan Group AG via Globenewswire

Copyright © Thomson Reuters 2019. All rights reserved.
Press Releases
Cristina Stenbeck, Erik Mitteregger and Mario Queiroz will not stand for re-election in 2019, and the Nomination Committee proposes two new Directors to the Kinnevik Board  
Jan 18, 2019 08:00 ET
Bavarian Nordic Announces Exercise of USD 44 Million Option by the U.S. Government under Contract for Freeze-dried MVA-BN® Smallpox Vaccine  
Jan 18, 2019 07:15 ET
Ethan Allen Announces Earnings Release Date for Fiscal 2019 Second Quarter Results  
Jan 17, 2019 22:30 ET
Ossur Hf : Q4&FY 2018 Results - Conference call Tuesday 5 February at 9:00 CET  
Jan 17, 2019 13:42 ET
REC Silicon - Presentation at the Pareto Securities Power and Renewable Energy Conference 2019  
Jan 17, 2019 13:40 ET
INGREDION TO RELEASE 2018 FOURTH-QUARTER AND YEAR-END FINANCIAL RESULTS AND HOLD CONFERENCE CALL AND WEBCAST ON TUESDAY, FEBRUARY 5, 2019  
Jan 15, 2019 01:59 ET
Eastman Schedules Fourth-Quarter and Full-Year 2018 Financial Results News Release and SEC Form 8-K Filing, Teleconference and Webcast  
Jan 10, 2019 23:29 ET
Particle Sciences strengthens nanomilling offering with new API screening program  
Jan 9, 2019 21:59 ET
Lubrizol Performance Coatings Group Introduces New Blog Page  
Jan 8, 2019 22:29 ET
Verisk Launches Black Box 3  
Jan 8, 2019 21:59 ET
More News >>
Copyright © 2019 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 5791 1818

Connect With us: